Anna Mowry - 24 Nov 2021 Form 4 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Role
CFO and Treasurer
Signature
/s/ Anna Mowry
Issuer symbol
NAUT
Transactions as of
24 Nov 2021
Net transactions value
+$68,632
Form type
4
Filing time
24 Nov 2021, 16:12:33 UTC
Previous filing
16 Aug 2021
Next filing
25 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAUT Common Stock Purchase $68,632 +15,000 +86% $4.58 32,500 24 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 15,000 shares purchased in the price range of $4.545 to $4.58 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.